Tag: comorbidity
Executive Functioning in Children and Adolescents with ADHD and Disruptive Behavior Disorders
by Rosa Elena Ulloa Flores, MD, PhD; Ricardo Díaz Sánchez, BS; Francisco R. de la Peña, MD, MS; Marcos F. Rosetti Sciutto, PhD; Lino Palacios Cruz, MD, PhD; and Pablo Mayer Villa, MD, MS Dr. Ulloa Flores is with Hospital Psiquiátrico Infantil Dr. Juan N. Navarro, in México City, México. Mr. Díaz Sánchez is with Arete […]
Transition from Obsession to Delusion in Schizo-obsessive Disorder: A Case Report and Literature Overview
By Estevão Scotti-Muzzi, MD, MS, and Osvaldo Luis Saide, MD, PhD Drs. Scotti-Muzzi and Saide are with the Psychiatry Unit, Pedro Ernesto University Hospital, State University of Rio de Janeiro, Brazil. Funding: No funding was provided. Disclosures: The authors have no conflicts of interest relevant to the content of this article. Abstract: Schizo-obsessive disorder has been […]
Letter to the Editor: Gabapentin Abuse in a Patient with Comorbid Mood and Substance Use Disorders
Innov Clin Neurosci. 2016;13(7–8):13–14. Dear Editor: Substance use disorders frequently coexist with and complicate the treatment of mood and anxiety disorders. Gabapentin is one of the most commonly prescribed off-label medications in psychiatric settings.[1] Despite limited evidence, it has been used frequently in the treatment of mood and anxiety disorders in patients with comorbid substance […]
Complex Diagnostic and Treatment Issues in Psychotic Symptoms Associated with Narcolepsy
by Sricharan Moturi, MD, MPH, and Anna Ivanenko MD, PhD Drs. Moturi and Ivanenko are from the Division of Child and Adolescent Psychiatry, Children’s Memorial Hospital, Chicago, Illinois. Dr. Ivanenko is also from the Children’s Memorial at Central DuPage Hospital, Winfield, Illinois.
Treatment of Migraine and the Role of Psychiatric Medications
by Elisa Cascade; Amir H. Kalali, MD; and Todd A. Smitherman, PhD Ms. Cascade is Vice President, Quintiles Inc./iGuard, Falls Church, Virginia; and Dr. Kalali is Vice President, Global Therapeutic Group Leader CNS, Quintiles Inc., San Diego, California, and Professor of Psychiatry, University of California, San Diego; and Dr. Smitherman is Assistant Professor, Department of […]
Should DSM-V Designate “Internet Addiction” a Mental Disorder?
by Ronald Pies MD Dr. Pies is Professor of Psychiatry, SUNY Upstate Medical University, Syracuse, New York, and Clinical Professor of Psychiatry, Tufts University School of Medicine, Boston, Massachusetts.
Continue Reading